疾患特異的iPS細胞株。チェディアック・東症候群患者由来。エピソーマルベクターにより6因子（Oct3/4, Sox2, Klf4, L-Myc, Lin28, p53-shRNA）を導入して樹立。Feeder free培養。緩慢冷却法保存。
1) 非営利の団体に所属する利用者による学術研究に限る。 2) 寄託者から承諾を得ること。3) <a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/non-profit.pdf' target="_blank">別紙1 (非営利) </a>を提供同意書 (C-0003) に添付すること。4) 先ずは、<a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line 問い合わせ&">理研細胞バンク</a>にお問い合わせください 。
1) The BIOLOGICAL RESOURCE must be used for academic research purpose conducted by RECIPIENT who belongs to a not-for profit academic organization (i.e. a university or another institution of higher education or any non-profit scientific or educational organization, including government agencies) . 2) The RECIPIENT agrees to obtain the prior written approval of the distribution from the APPROVER. 3) Attach <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/non-profit_en.pdf' target="_blank">TERMS and CONDITIONS (non-for-profit) </a> to MTA (C-0007) . 4) Contact Us : <a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line&">RIKEN Cell Bank</a>
Disease specific iPS cell line derived from a patient : Chédiak-Higashi syndrome. Order Form (C-0042, C-0057, C-0007).
Disease specific iPS cell line derived from a patient : Chédiak-Higashi syndrome.
HPS0515
HPS0515